Mercy BioAnalytics, Inc.

📍 Waltham, United States🗓 Founded 2018👥 35 employees💰 Last funded 2021
Biotechnology Research🌐 mercybio.com
Website LinkedIn
Mercy BioAnalytics is on a mission to save lives and relieve suffering across the globe through the early detection of cancer. We have developed a novel liquid biopsy assay platform which interrogates tumor-derived extracellular vesicles, which are abundant in blood and carry information about their cell of origin, enabling detection of cancer even in at the earliest stages. 
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Mercy BioAnalytics, Inc.?
Mercy BioAnalytics, Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did Mercy BioAnalytics, Inc. last raise funding?
The most recent investment in Mercy BioAnalytics, Inc. recorded on gritt.io was in 2021.
When was Mercy BioAnalytics, Inc. founded?
Mercy BioAnalytics, Inc. was founded in 2018.
What industry is Mercy BioAnalytics, Inc. in?
Mercy BioAnalytics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Mercy BioAnalytics, Inc. based?
Mercy BioAnalytics, Inc. is headquartered in Waltham, United States.